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http://dx.doi.org/10.1016/j.jprot.2013.10.025A B S T R A C TAvailable online 29 October 2013 In order to characterize newborn mouse gut microbiota phylotypes in very early-life stages,
an original metaproteomic pipeline, based on LC–MS2-spectra and Mascot driven NCBI
non-redundant repository database interrogation was developed. An original computational
analysis assisted in the generation of a taxonomic gut architecture from protein hits to
operational taxonomic units (OTUs) and related functional categories. Regardless of the
mouse's genetic background, a prevalence of Firmicutes (Lactobacillaceae) and Proteobacteria
(Enterobacteriaceae) was observed among the entire Eubacteria taxonomic node. However, a
higher abundance of Firmicutes was retrieved for Balb/c gut microbiota compared to Rag2ko
mice, the latter was mainly characterized by a Proteobacteria enriched microbiota. The
metaproteomic-obtained OTUs were supported, for the identification (ID) of the cultivable
bacteria fraction, corroborated by axenic culture-based MALDI-TOF MS IDs. Particularly,
functional analysis of Rag2ko mice gut microbiota proteins revealed the presence of abundant
glutathione, riboflavin metabolism and pentose phosphate pathway components, possibly
related to genetic background.
Themetaproteomic pipeline herein presentedmay represent a useful tool to investigate the
highly debated onset of the human gut microbiota in the first days of life, when the bacterial
composition, despite its very low diversity (complexity), is still very far from an exhaustive
description and other complex microbial consortia.Keywords:
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The manuscript deals with a “frontier” topic regarding the study of the gut microbiota and
the application of a metaproteomic pipeline to unveil the complexity of this fascinating
ecosystem at the very early stages of life. Indeed during these phases, its diversity is very
low but the bacterial content is highly “instable”, and the relative balance between mucosal
and fecal bacteria starts its dynamics of “fight” to get homeostasis. However, in the
neonatal period, especially immediately after birth, a comprehensive description of this
microbial eco-organ is still lacking, while it should be mandatory to highlight its first
mechanisms of homeostasis and perturbation, while it co-develops with and within the
host species.
In order to unravel its low but almost unknown microbial community multiplicity, the
newborn mouse gut, characterized by a “very” low complexity, was herein selected as
model to design a LC–MS
2
-based shotgun metaproteomic approach, potentially suitable to
study onset and shaping in human newborns. A microbiological semi-automatic compu-
tational analysis was performed to infer gut phylotypes; such as proof of evidence, related
OTUs were compared to axenic-culture-based MALDI-TOF MS IDs showing consistency at
family and phyla levels for the bacterial cultivable fraction.
This article is part of a Special Issue entitled: Trends in Microbial Proteomics.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction
Complex ecosystems of host and microbial cells are organized
into diverse ecological niches (e.g., teeth, mouth, nose and
respiratory district, gut, and genito-urinary tract) inside mam-
malian organisms. In each district different groups of microbes
(phylotypes) form communities that change across space
(e.g., spatial variability determinants) and time (e.g., age variabil-
ity determinants) [1] Cohabitation with microbes is the product
of a long evolutionary pathway resulting in a relationship based
onmutual advantages that in humans is essential for health [2].
The human body together with “its” microbes has been
defined as superorganism [3] and because hosting billions of
microbes benefits their genes, proteins and metabolites
acquiring additional functions and thus amplifying growth
and survival tools. The superorganism description needs a
new system biology-based approach, employing either
metagenomic or metaproteomic strategies, which offers a
new holistic paradigm of the human biological ontology [4].
Thedevelopment ofmetagenomic studieshas arisen fromthe
need to interpret the vast data sets of sequences produced by the
microbial genomeprojects [5], and to link their annotations to the
functional counterpart in the context of body habitats. Indeed, in
thesehabitats the bacteria establish a dynamic interplaywith the
host, generating the microbiome [6]. Metaproteomics, instead,
analyzes protein patterns expressed in the ecosystems and thus
describes the real-time dynamics of the systems [7]. In this
context, a full comprehensive description of human gut phylo-
types is essential to interpret gut homeostasis and perturbation
[8–11].
In order to unravel gut microbial community multiplicity
at the very early stages of life, the mouse gut, which is
characterized by a lower gut complexity than the humans [12],
may represent an appropriate model to design interpretative
pipelines in metaproteomic analyses for studies on neonatal
gut microbiota onset and development [13,14]. Indeed, during
these stages, microbiota diversity is extremely low and the
bacterial content is highly “instable”, with a topographic andmetabolic balance tremendously depending on the respective
mucosal and fecal bacteria counterparts, which starts their
fight dynamics to get homeostasis [15]. However, for obvious
ethical issues studies onmucosal bacterial contents cannot be
performed in neonatal age, and gut topographical-related
results can be therefore inferred by employing newborn
mouse models. Remarkably, the bacterial complexity and
also its contents is particularly affected by the mucosal
surface extension [16] hence providing low bacterial content
which can actually be related to the very small surfaces of the
newborn mice. Indeed, also the pivotal metaproteomic study
of Li et al. [17] on the human mucosal luminal interface,
performed on healthy adults enrolled in a cancer surveillance
program, showed the limited presence of distinct proteins
(i.e., 49) associated to biogeographic features, suggesting a
possible low diversity index of the mucosal bacterial-
associated communities, which can be obviously more re-
strained in the very early life stages. In fact, to the best of our
knowledge up to now, metaproteomic studies on mammalian
gut microbiota have been mainly based on the fecal content,
either gel-based [18–20], or gel-free [21,22] approaches.
However, sample complexity remains a very significant
issue and the fewmetaproteomic studies performed on rodents
gut microbiota have been exploiting either 1D-SDS gel electro-
phoresis or isoelectrofocusing as the first fractionation step, at
the protein or peptide level, prior to LC–MS2 injection analysis
[12–14,23].
As a descriptive approach, we chose a common shotgun
proteomics experiment, relying on a monodimensional
reverse-phase (RP) chromatography, adjusting the gradient
time in order to obtain the maximum spreading of peptides
along the whole run time, thus minimizing ion suppression
at the ESI source. Tandem MS was performed on a fast
scanning 3D-ion trap, coupled to a Biotyper MALDI-TOF MS
for the complementary analysis of the cultivable bacterial
fraction. The herein study mainly aimed at describing mouse
gut enterotypes during very early life stages (e.g., program-
ming phase), when limited microbial content is expected [15]
19J O U R N A L O F P R O T E O M I C S 9 7 ( 2 0 1 4 ) 1 7 – 2 6and metaproteomic analysis can actually improve the
mucosal-associated gut microbiota description, still almost
unknown and whose cultivable portion can be performed by
MALDI-TOF MS. Briefly, an overall of 18 Balb/c and Balb/
c-Rag2ko baby mice were sacrificed at 3, 7, and 14 days after
birth (three mice for each time point); their intestines were
entirely removed and subjected, after suitable treatment, to
axenic culture-basedMALDI-TOFMS identifications (IDs) and
to a metaproteomic workflow consisting of nano HPLC/MS2
analysis coupled to an automatic bioinformatic algorithm for
bacterial operational taxonomic unit (OTU) description.
Indeed, our metaproteomic pipeline comprised data process-
ing and Mascot DB search, coupled with an automatic
computational procedure to translate the Mascot outputs
into mouse gut phylotypes at the level of either bacterial
phyla or families. Microbial protein IDs were further
complemented by functional categories retrieved by Cluster
of Orthologous Group (COG) database interrogation.
Although the number of identifiedproteinswas rather low, a
good agreement, in terms of major phylotype (phyla) descrip-
tion, was ascertained by culture-dependent MALDI-TOF MS IDs
and metaproteomics, suggesting a link between mouse genetic
background (Balb/c and Rag2ko mice) and gut microbiota
shaping in the very early stages of life.2. Materials and methods
2.1. Mice
Balb/c and Balb/c-Rag2ko animals were cared in conventional
pathogen-free conditions at the Centro Ricerche Sperimentali,
Istituto Regina Elena (Roma, Italy). Three groups, each com-
posed of three baby mice of Balb/c and Balb/c-Rag2ko, were
established. All baby mice were kept with their mothers until
analysis. Themicewere sacrificed at 3, 7 and 14 days after birth;
the whole intestine, from the duodenum to the rectal tract, was
removed and collected into sterile 1.5 ml Eppendorf tubes. All
procedures with animals were performed in compliance with
the relevant laws and local institutional guidelines.
2.2. Bacterial recovery from mouse intestine
Bacterial recovery of mouse intestine was performed by
following the procedure of Apajalahti et al. [24]. The intestines,
from duodenum to the rectum, were mechanically homoge-
nized in 10 ml of Hanks' balanced salt solution (HBSS), using a
Stomacher 80 Biomaster (Seward Limited, Worthing, UK) for
1 min at high speed, and intestinal macro-debris was removed
by several low speed centrifugation (200 ×g for 15 min).
Subsequently, cleared supernatants were high-speed serial
centrifuged at 30,000 ×g for 15 min. The pellets were suspended
into 500 μl HBSS and screened by microscopy to evaluate
bacterial recovery (90%), hence providing the enriched bacteria
suspensions (EBSs) [24].
2.3. Culture-based MALDI-TOF MS bacterial IDs
Ten out of 500 μl EBSs from baby mice were plated either onto
elective Columbia (5% sheep blood) agar (COS), PolyViteX bloodagar (PVX) and Schaedler Anaerobe blood agar (SCS) plates
(bioMérieux,Marcy l'Etoile, France) and incubated at 37 °C for 48–
72 h, in aerobic, microaerophilic and anaerobe growth condi-
tions by using generator bags for microaerophilic and anaerobic
bacteria (bioMérieux, Marcy l'Etoile, France), respectively. A
bacterial cell density was estimated, by streaking serial dilutions
of EBSs onto COS, ranging from 105 to 107 colony forming units/
ml for the entire set of starting sample homogenates. Based on
morphology and growth conditions, colonieswere characterized
and re-isolated onto COS, PVX and SCS agar plates in order to
proceed with the MALDI-TOF MS-based IDs performed with a
Microflex LT mass spectrometer (Bruker Daltonics, GmbH,
Bremen, Germany), using Flex Control (version 3.0) and MALDI
Biotyper automation control (version 2.0) software. In particular,
bacterial cells were directly picked from isolated colonies with a
10 μl tip, smeared in triplicate onto an MSP 96 polished steel
target (Bruker DaltonikDaltonics) and air-dried at RT. Each
sample was overlaid with 1.5 μl of matrix, which consisted of a
saturated solution of α-cyano-4-hydroxy-cinnamic acid (Bruker
DaltonikDaltonics) in 50% acetonitrile–2.5% trifluoroacetic acid
(Sigma-Aldrich). The matrix/sample was co-crystallized by air
drying at RT. Three-hundred shots, in 50-shot steps from
different positions of the target spot (automatic mode) were
collected from each spectrum (mass range of 2000 to 20,000 Da).
Spectral analyses and bacterial IDs were automatically per-
formed with default settings without any user intervention. The
generated peak listswere used formatches against the reference
library (version 2.0 SR 1; Bruker Daltonics) directly using the
integrated pattern-matching algorithm of the MALDI Biotyper
automation control. The software provides a log score, and the
cut-off score of 2 was used to validate ID at the species level, as
recommended by the manufacturer. From all bacterial isolates,
characterized at species levels, the complete bacterial lineages
were retrieved and themouse gut microbiota represented at the
level of phyla was inferred.
2.4. Metaproteomic analysis pipeline
Two-hundred out of 500 μl EBSs from Balb/c and Rag2ko
babies mice, sacrificed at 3, 7 and 14 days, were centrifuged
at 10,000 ×g for 15 min, resuspended into 200 μl sample
buffer (7 M urea, 2 M thiourea, 40 mM Tris base, 4% CHAPS,
50 mMDTT), pre-warmed at 37 °C, sonicated for 20 s (5×) and
then incubated for 1 h at 37 °C. About 100 μg of proteins were
submitted to reduction with 50 mM DTT for 1 h at 37 °C,
alkylation with 100 mM iodoacetamide (IAA) for 1 h at RT
and finally digested on with 2 μl of 0.5 μg/μl of trypsin at
37 °C.
Tryptic digests were analyzed by nLC–MS on a Proxeon
EASY-nLCII (Thermo Fisher Scientific, Milan, Italy) interfaced
with an amaZon ETD Ion Trap (Bruker Daltonics). 2 μl (about
400 ng of tryptic digest) from each samples was injected in
duplicate (intra-assay replicate) and pre-concentrated for
3 min on a C18-A1 EASY-Column™ (2 cm, 100 μm I.D., 5 μm
p.s., Thermo Fisher Scientific) at a flow rate of 5 μl/min. A
gradient elution was performed on a C18-Acclaim PepMap
(25 cm, 75 μm I.D., 5 μm p.s., Thermo Fisher Scientific), at a
flow rate: 0.3 μl/min, T of 20 °C; eluents: A, H2O + 0.1%
HCOOH and B, CH3CN + 0.1% HCOOH; gradient: from 3 to
30% B in 180 min.
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definition for data dependent acquisition) using the
ultrascan resolution as scan mode (32,000 m/z sec−1). Three
precursor ions were selected for each survey scan, keeping
the active exclusion enabled for 30 s after 2 MS2 scans on the
same precursor. Raw data were processed with the Mascot
distiller software (version 2.3.2.0, Matrix Science) to generate
a peak list for database searching. Protein IDs were per-
formed by Mascot server 2.3 version running on a locally
resident cluster using the NCBI non-redundant database
version (September 2012). Searching was restricted to bacte-
ria (Eubacteria) as taxonomy entry, setting carbamidometh-
ylation of cysteines as fixed modification and oxidation of
methionines as variable modification, allowing one missing
cleavage. Maximal error tolerances of 0.4 Da and 0.5 Da were
chosen for parent and fragment ions, respectively, according
with the low resolution mass analyzer, and providing a false
discovery rate (FDR) below 1%, after Mascot Percolator score
filtering.
2.5. Mascot outcome automatization processing
In theMascot output, peptideswere assembled in protein hits all
of which were associated to different groups of homologous
proteins shared by distinct OTUs. Only hits with at least one
“bold red” peptide and a protein score higher than 39 were
considered for the analysis. These data were exported in a
comma-separated value (CSV) format and analyzed by two Excel
macros, able to automatically convert protein hits in mouse gut
phylotypes, hence reported at the level of bacterial phyla and
families. The Mascot CSV file was simplified to obtain a final
protein hit list table, correlated with their respective taxonomy
code number (only “prot_hit_num” and “prot taxa id” columns
were taken into consideration). A library of 280195 taxonomy
code numbers of microorganisms belonging to Bacteria and
ArchaeaKingdomswere created and linkedwith their respective
phyla and bacterial family names. A comparison between the
taxonomy code numbers present in “prot taxa id” column of
Mascot output and those present in the taxonomy code library
was performed, thus generating in the Mascot output a list of
protein hits associated to their respective phylotypes at phyla
and bacterial family levels. The presence of phyla or family
redundancies within each protein hit was removed by using the
“Remove duplicates” function of Excel 2007 software. The
resulting unique phyla and family names were indexed in
alphabetical order and enumerated to show the gut microbiota
composition (see Supplementary Material, SM1 for the descrip-
tion of manual and automated procedures for conversion of
Mascot protein hits intoOTUs, SM2, 3 for the operational steps of
the manual procedure (e.g., exported CSV-bacterial and phyla
counts, 8 sheets; library of 280195 taxonomy code numbers),
SM4–6 (phyla macro), SM4, 7–8 (families' macro).
2.6. Functional annotation
To characterize the functional properties of protein hits
identified by our metaproteomic pipeline the Clusters of
Orthologous Group (COG) database was used, probing protein
name against gene function groups defined within the COG
database (http://www.ncbi.nlm.nih.gov/COG/).3. Results and discussion
Themetaproteomic pipelinewas applied to the characterization
of gut microbiota in wild-type Balb/c and Balb/c-Rag2ko mice
(here nominated as Rag2ko), that are expected to have different
microbial composition [25]. Recombination activating gene
(RAG) deficient Rag2ko mice are severely immunodeficient,
because of the RAG-2 gene mutation which hampers the IgA
assembling, hence affecting secretory IgA (IgAs) levels inmother
milk and B and T cell generations [26]. In the absence of immune
defenses, microbial colonization and propagation cannot be
driven by the host [25]. The effects of the immune system are
instead fully effective in Balb/c mice. In this study, 18 baby mice
(namely 1–18) from: i) Balb/c ♀ × Rag2ko ♂ at days 3 (samples
1–3), 7 (samples 4–6) and14 (samples 7–9); and ii) Rag2ko♀ × Balb/
c♂ at days 3 (samples 10–12), 7 (samples 13–15) and 14 (samples
16–18) were sacrificed and their entire intestines were processed
(Fig. 1A and B). Samples were homogenized and subjected to the
bacterial enrichment procedure to obtain EBS fractions (Fig. 2A)
[24], for further MALDI-TOF MS-based bacterial IDs and
metaproteomic analyses (Fig. 2B and C).
3.1. Microbiota analysis by axenic culture-based
MALDI-TOF MS approach
In order to determine the early mouse gut microbiota
composition, from the streaking on plates of bacterial liquid
cultures an overall of 50 distinct individual colonies, charac-
terized by different morphological (e.g., size, shape and color
characteristics) and metabolic (e.g., aerobic, anaerobic,
microaerophilic conditions and differential growth factor
requirements) features (types), were selected, and picked
from the plates after a 48–72 hour growth time. The lowest
bacterial cell density (105 colony forming units, CFU/ml) was
obtained for Balb/c and Rag2ko mice at 3 days, probably
correlated to the early mouse life stage, whereas the highest
(107 CFU/ml) was calculated for Rag2ko mice at 14 days. By
MALDI-TOF MS Biotyper we identified a total of 14 different
species, showing a different distribution linked to the mouse
age and genetic background. Each mouse belonging to the
same time group presented a similar composition at bacterial
species level which resulted in a small variation of the
distribution of Proteobacteria and Firmicute levels (Fig. 2B
and C). At 3 days we can actually deal with only or prevalently
mucosal adherent bacteria in mouse because of the scarce-
ness of the fecal content. Indeed, if we think that a human
gastrointestinal (GI) tract from an adult is about 200–300 m2
[16] and is colonized by 1013–14 bacteria of 400 different
species, it is expectable that the intestine of a 3 days old
mouse, which is 1.1 cm2 (Fig. 1), can host theoretically a
number of bacteria which should be 107, because of a 6 Log of
difference between the mouse gut area at 3 days of life and
the adult human gut area. However, the issue to point out is
that the number of bacteria is closely related to the topo-
graphic complexity of the GI tract: it is extremely simple in the
first days of life when the GI tract is very small, with the
consequence that in the early days after birth there is very low
variety of bacterial species composing the microbiota, as
demonstrated by Koenig et al. [15], who have introduced a
3 DAYS
7 DAYS
14 DAYS
A
B
Fig. 1 – The mouse gut anatomy. A schematic representation of a mouse intestine (panel A) and images describing the organ
accretion at 3, 7 and 14 days (panel B). The scheme A was modified from Kleerebezem and Vaughan (Annu Rev Microbiol
2009;63:269–90).
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species multiplicity and hence its complexity in species [15].
Indeed, we can expect that the species present at the very
early stage of the mouse life, can be much less than 400, most
of them probably not cultivable. In Fig. 3, it is clearly shown
that gut microbiota of Balb/c and Rag2ko baby mice were
composed exclusively of microbial isolates belonging to
Firmicutes and Proteobacteria phyla. In particular, the gut
microbiota at 3 days was similar in both types of mice, with a
predominance of Firmicutes (95% in Balb/c and 75% in Rag2ko
mice) and lower levels of Proteobacteria (Fig. 3). During the
succeeding time points (7 and 14 days), the relative abun-
dance of Proteobacteria in Balb/c mice started to increase
reaching 50% of the entire gut microbiota at 14 days (Fig. 3). At
the same time points, Rag2ko mice showed higher level of
Proteobacteria than Balb/c mice, reaching the level of 75% at
14 days (Fig. 3). Regarding the composition at bacterial species
level within the Proteobacteria phylum, the Rag2ko baby mice
at 3 days of age, presented numerous bacterial isolates
belonging to Pasteurella pneumotropica (about 20%), while only
Escherichia coli isolates were identified in the subsequent time
points (data not shown). The bacterial core, even if limited to
the cultivable bacterial fraction, result is dependent on the
genetic background and on the gut microbiota developmentstages (mouse age). Remarkably, the bacterial cultivable
fraction was consistent with that described in the pivotal
papers on the onset and development of the mouse gut
microbiota [27–29]. Moreover, in these papers, the description
of the relative amounts of themain bacteria groups in the first
days of mouse life showed that actually, it is limited not only
on the bacterial complexity (e.g., only few OTUs) but also on
the number of bacterial cells ascribed to each bacterial type
(e.g., 103 Lactobacilli and Streptococci or 101 Enterococci at
2 days).
No bacterial isolates belonging to other phyla different from
Proteobacteria and Firmicutes (in particular Bacteroidetes and
Actinobacteria) were characterized by our culture-based ap-
proach, probably due to their demanding culture condition
required for bacterial in-vitro growth.
3.2. Microbiota analysis by metaproteomic–bioinformatic
pipeline
Database searches performed with Mascot 2.3 running on a
resident machine returned an overall of 997 protein hits for all
mice (compared to 892 hits for the corresponding intra-assay
replicates) ranging an average number of 46 ± 7 for Balb/c
mice at 3 days (samples 1–3) to 83 ± 2 for Rag2ko mice at
MALDI-TOF MS WORKFLOW
PEPTIDES 
colonies 
MS SPECTRA
MICROFLEX LT
OPERATIONAL PIPELINE FOR MICROBIOTA  ANALYSIS
Bacterial purification
GUT HOMOGENATE
MUCOSAL AND 
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A
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C
B
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Fig. 2 – Experimental pipeline employed to characterize the mouse gut microbiota. The pipeline consisted of three steps:
bacterial enrichment from mouse intestine (panel A); microbial ID assessment by MALDI-TOF MS Biotyper (panel B);
LC–MS2-based metaproteomic/bioinformatic pipeline (panel C).
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protein hits was found for Balb/c and Rag2ko mice at 3 days
(samples 1–3 and 10–12, 137 and 139 protein hits, respectively;Balb/c Rag2ko
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Fig. 3 – Taxonomic classification of Balb/c and Rag2ko gut
microbiota characterized by axenic-based MALDI-TOF MS
approach. Bar charts showing the relative abundance (%) of
bacterial phyla characterized from Balb/c and Rag2ko mice
intestine at different time points (3, 7 and 14 days) are
presented. Bacterial isolates are described at phyla level.
Each bar refers to a group of three mice.SM9), probably due to the physiology of the intestinal
maturation, and the bacterial population dynamics in the
early stages of intestinal colonization of mouse gut [30]. A
good technical reproducibility was obtained (an overall of 710/
997 protein hits were found; 71.2%) ranging from 61.9% in
Balb/c mice at 7 days (sample 4) to 91.3% in Rag2ko mice at
7 days (sample 14) (SM9). Even if a low number of protein hits
was found, a small variation in their levels was calculated by
standard deviation within the three mice of the same time
group, thus supporting the validity of the experimental
setting presented in this manuscript (SM9). The comparison
of mouse protein hits belonging to the same time group
(biological replicates) revealed that a consistent group of
proteins hits was shared among them (SM9). In particular,
the level of overlay was comprised between 59.1% in Balb/c
mice at 3 days and 88.7% in Rag2ko mice at 7 days when a
protein hit was shared by 2 out of the 3 mice of the same time
group (SM9).
An analysis performed using Mascot coupled with a mouse
reference proteome returned in an overall of 96 protein hits
(SM10), approximately 1/10 of the entire protein catalog
obtained with the Mascot Eubacteria database. Fifty-nine out
of the 96 protein hits (62%) were related to only 9 proteins,
namely 78 kDa glucose-regulated protein, heat shock 70 kDa
protein, serum albumin, microsomal triglyceride transfer
23J O U R N A L O F P R O T E O M I C S 9 7 ( 2 0 1 4 ) 1 7 – 2 6protein large subunit, liver fatty acid-binding protein, inactive
pancreatic lipase-related protein 1, melanotransferrin,
nesprin and titin (SM10).
All protein hits were classified among 17 different phyla
(Fig. 4A). Interestingly, the number of inferred species, ranging
from100 to 200 for eachmouse genetic background at each time
point of the growth (SM11), overcame 1 Log of the number of
cultivable species identified by MALDI-TOF MS. High level of
protein hits related to Firmicutes and Proteobacteria was found
in both mouse offsprings, while only Balb/c mice showedBalb/c Rag2ko
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Fig. 4 – Taxonomic classification of Balb/c and Rag2ko gut
microbiota characterized by metaproteomic pipeline. Bar
charts showing the relative abundance (%) of major bacterial
phyla in the gut microbiota of Balb/c and Rag2ko mice, are
reported. Each bar represents a group of three mice (panel A).
Inset on detailed relative abundance (%) of families in
Firmicutes and Proteobacteria phyla (panels B and C,
respectively).significant levels (>5%) of Bacteroidetes and Actinobacteria.
Firmicutes and Proteobacteria protein hits were differentially
found in Balb/c and Rag2ko baby mice. At 3 days Balb/c mice
presented with 75% of hits belonging to Firmicutes and 20%
associated to Proteobacteria, while an inverse distribution was
observed in Rag2komice (Fig. 4A). In the subsequent time points,
the level of protein hits related to Proteobacteria started to
increase in both mouse lineages, reaching at 14 days, by 50% of
the overall phyla in Balb/c and the astonishing level of 90% in
Rag2ko mice (Fig. 4A). In the same manner, at 7 and 14 days the
levels of Actinobacteria and Bacteroidetes protein hits belonged
exclusively to Balb/c (5%, and 10%, respectively) (Fig. 4A). Similar
results were obtained by intra-assay replicates (Fig. S1).
To get further information about the composition of mouse
gut microbiota, we perform an in-depth taxonomic analysis at
the level of bacterial family for all protein hits characterized by
the metaproteomic pipeline. With this aim, bacterial family
level of protein hits within the most abundant Firmicutes and
Proteobacteria phyla was calculated (Fig. 4B and C). In Balb/c
mice, for all time points, within the Firmicutes phylum, a
predominant number of Lactobacillaceae-related protein hits
(>60%) was computed (Fig. 4B). In Rag2ko, protein hits related to
Streptococcaceae (20%), Lactobacillaceae (25%) and Listeriaceae
(50%) families were found at 3 days (Fig. 4B), while at 7 and
14 days Rag2ko presented a completely different taxonomywith
variable levels of protein hits related to Lactobacillaceae
(from 50% to 2% at 7 and 14 days, respectively), progressively
loosing Streptococcaceae and Listeriaceae (Fig. 4B). Regarding
Proteobacteria, the analysis at the family level of all protein hits,
showed that the great majority was ascribed to the Enterobac-
teriaceae family in both mouse lineages and for all time points
(with the exception of Rag2ko mice at 3 days of age) (Fig. 4C).
We emphasize that the relative abundance of protein hits
related to Enterobacteriaceae family in Rag2ko mice at 7 and
14 days, was greater than 90%, while at the same time points, it
did not exceed the 50% in Balb/c mice (Fig. 4C). The bacterial
family composition of protein hits belonging to Proteobacteria
phylum in Rag2ko mice at 3 days was completely different to
that present at 7 and 14 days, with low level of Enterobacteri-
aceae (<5%) and very high level of Pasteurellaceae (>85%)
(Fig. 4C). The different bacterial family composition within
Proteobacteria phylum of Rag2ko mice at 3 days was confirmed
by culture-based MALDI-TOF MS approach in which a relevant
level of bacterial isolates belonging to Pasteurellaceae (20%) and
low abundance of Enterobacteriaceae were found (see above).
Intriguingly, in Rag2ko mice at 7 and 14 days a complete
replacement of Pasteurellaceae to Enterobacteriaceae was
observed (see above).
By comparing culture-based MALDI-TOF MS and
metaproteomic results for both mice offsprings, opposite
trends for Proteobacteria and Firmicute relative abundance
were observed through the time-course (Figs. 3 and 4A).
However, the Proteobacteria abundance was higher in Rag2ko
than in Balb/cmice. Indeed, at 14 days, Proteobacteria in Rag2ko
represented the 90% and 75% of the total gut microbiota, by
metaproteomics and MALDI-TOF MS IDs, respectively, while at
the same time-point Balb/c mice presented significant lower
levels (40% and 55%, respectively) (Figs. 3 and 4A). The results
herein presented seem to suggest a link betweenmouse genetic
background and gut microbiota shaping, showing an important
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Firmicutes and Actinobacteria, and Bacteroidetes, respectively,
in the case of Rag2ko mice.
Most of the published works on the characterization and
variation of human gut microbiota through life stages and
during diseases have been approached by metagenomics
[15,31,32], and only few by metaproteomic pipelines applied
to adult subjects [19,20,22,23]. Since the correct development/
maturation of mammal gut microbiota in adults is intimately
correlated with programming processes established since the
very early life stages, it becomes essential to set up specific
procedures to be able to highlight and to characterize gut
microbial structure and alteration in childhood, by using
appropriate models especially for the very early life stages,
when competition between mucosal and fecal bacteria
induced the next microbiota shaping. For these reasons, we
carried out a metaproteomic pipeline applied to newborn
mouse gut samples, despite operational difficulties due to
sample scarceness, organ homogenate preparation and low
bacterial complexity. The workflow was integrated with an
automatic bioinformatic algorithm for gut microbiota OTU
generation and the obtained results were compared to axenic
culture-based MALDI-TOF MS evidences.
3.3. Protein classification by COG categories
Among the 997 Mascot protein hits, only hits belonging to
Firmicutes and Proteobacteria major phyla (946/997) were
subjected to COG categorization, as shown in Fig. 5. According
to the COG nomenclature (http://www.ncbi.nlm.nih.gov/COG/),
we grouped similar COG categories into four main classes,
namely: i) information storage and processing; ii) cellular
processes and signaling; iii) metabolism; and iv) poorly charac-
terized. Themost prevalent proteins belonged to (i) class,mainly
including elongation factors (e.g., Tu, Ts, G), and ribosomal
proteins (e.g., 30S and50S). The (ii) class is presentedwithmostly
proteins belonging to chaperons (e.g., DnaK, Skp, GroEL and
GroES), outer membrane protein A, flagellin, thioredoxin andBalb/c Rag2ko Bal
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Fig. 5 – COG functional category distribution associated to Firmic
relative abundance (%) of Mascot protein hits associated to Firmic
different time points (3, 7 and 14 days). Each bar represents COGperoxiredoxin. The (iii) class is comprised of proteins belonging
to enolase, phosphoglycerate, transaldolase, phosphoglycerate
kinase, deoxyribose-phosphate aldolase, L-lactate dehydroge-
nase, formate dehydrogenase, amino acid biosynthesis and
degradation. Finally, the (iv) class included proteinswith general
on unknown function. As shown in Fig. 5, COG groups'
comparison in Balb/c and Rag2ko mice, revealed absence of
time-dependant significant variation.
To get further functional insights, the 946 Mascot protein
hits were screened for the presence of proteins related to
specificmetabolic pathways, differentially expressed in Balb/c
or Rag2ko mice. The results allowed us to characterize, within
the Enterobacteriaceae family from Rag2ko mice, recurrent
presence of protein hits related to: i) peroxiredoxin (EC
1.11.1.15) and thioredoxin (EC 1.17.4.1) linked to glutathione
metabolism; ii) riboflavin synthase (EC 2.5.1.9) associated to
riboflavin metabolism; and iii) pentose phosphate pathway
related to ribose-phosphate pyrophosphokinase (EC 2.7.6.1),
transaldolase (EC 2.2.1.2) and deoxyribose-phosphate aldolase
(EC 4.1.2.4).
As reported for human Crohn's disease (CD) [33,34], the
Rag2ko functional picturemaybe associated to ahighpresence of
the family Enterobacteriaceae. Particularly, also Morgan et al,
found an increased abundance of genes associated to glutathi-
one, riboflavin metabolism and pentose phosphate pathway
[33]. Glutathione is a molecule specifically synthesized by
Proteobacteria to maintain gut homeostasis during oxidative
stress caused by inflammation [35]. Indeed, oxidized and
reduced glutathione conversion forms (riboflavin metabolism)
and pentose phosphate pathway (glutathione reduction), are
recruited in response to the presence of reactive oxygen and
nitrogen metabolites in the gut of CD patients [34,35]. The high
level of Enterobacteriaceae in the gut microbiota of both Rag2ko
and CD patients, might be the result of a positively driven
selection of microbes carrying pathways for oxidative
stress response via glutathione production and metabolism
[33,34]. Clearly the definition of functional ontological classifica-
tion would need higher dimensionality data sets, and theb/c Rag2ko
roteobacteria
147314
Poorly 
characterized
Metabolism
Cellular processes
Information 
storage and 
processing
age (days)
utes and Proteobacteria phyla. Bar charts show the COG
utes and Proteobacteria phyla from Balb/c and Rag2ko mice at
-groups retrieved from three mice.
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combined to the engineering of mass spectrometers [36–38] will
certainly play a central role in the future of metaproteomic
workflows.4. Conclusion
We developed a metaproteomic and computational-combined
pipeline which is able to characterize newborn mouse gut
microbiota. The design and setup of this procedure are
adequately wide-ranging to be employed with specific ad-hoc
customized databases for furthermetaproteomic study on other
host ecosystems in very early life stages, when mucosal and
fecal bacteria play their initial fight for the gut surface conquest,
imposing the next microbiota shaping from very low to adult
community complexity. We complemented our procedure by
comparing gut phylotype charts with those obtained with
axenic culture-based MALDI-TOF MS IDs. Intriguingly, agree-
ment between both approaches, was obtained for either
different mouse individuals, diverse genetic backgrounds and
programming time-course. However, a deep analysis of Mascot
protein hits retrieved from public repositories (e.g., NCBI and
UniProt), highlighted the presence of bacterial species usually
belonging to extreme life ecological niches (e.g., extremophilic
bacteria) [39]. For these reasons, we strongly believe that a
sensitive microbiological filter, is also required to correctly
screen and evaluate “gut-compatible” bacterial OTUs related to
proteins characterized by a metaproteomic pipeline.
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